Interleukin-19 downregulates interleukin-4-induced eotaxin production in human nasal fibroblasts

Allergology International

Volumn 60, Issue 4, 2011, Pages 449-457

  Higashino, Masaaki ^a   Takabayashi, Tetsuji ^b   Takahashi, Noboru ^b   Okamoto, Masayuki ^b   Narita, Norihiko ^b   Kojima, Akihiro ^b   Hyo, Sawako ^a   Kawata, Ryo ^a   Takenaka, Hiroshi ^a   Fujieda, Shigeharu ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

Eotaxin; Human nasal fibroblast; Interluekin 19; SOCS 1; STAT6

Indexed keywords

EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 19; INTERLEUKIN 4; PROTEIN TYROSINE KINASE INHIBITOR; RANTES; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 19; RECOMBINANT INTERLEUKIN 4; STAT6 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; SUPPRESSOR OF CYTOKINE SIGNALING 5; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; MEDIATOR; NOSE; NOSE FIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 83455172607     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-OA-0262     Document Type: Article

References (37)

1. Blumberg H, Conklin H, Xu WF et al. Interleukin 20: Discovery, receptor identification, and role in epidermal function. Cell 2001;104:9-19.
2. Commins S, Steinke JW, Borish L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 2008;12:1108-11.
3. Sabat R, Wallace E, Endesfelder S, Wolk K. IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases. Expert Opin Ther Targets 2007;11:601-12.
4. Gallagher G, Eskdale J, Jordan W et al. Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses. Int Immunopharmacol 2004;4: 615-26.
5. Liao SC, Cheng YC, Wang Y et al. IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J Immunol 2004;173:6712-8.
6. Oral HB, Kotenko SV, Yilmaz M et al. Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol 2006;36:380-8.
7. Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 2001;22:199-204.
8. Xing Z, Jordan M, Braciak T, Ohtoshi T, Gauldie J. Lipopolysaccharide induces expression of granulocyte/ macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts. Am J Respir Cell Mol Biol 1993;9:255-63.
9. Yamada T, Fujieda S, Yanagi S et al. IL-1 induced chemokine production through the association of Syk with TNF receptor-associated factor-6 in nasal fibroblast lines. J Immunol 2001;167:283-8.
10. Nonaka M, Ogihara N, Fukumoto A, Sakanushi A, Pawankar R, Yagi T. Toll-like receptor 2, 3, 4, 5 ligands and interleukin-4 synergistically induce TARC production in nasal polyp fibroblasts. Auris Nasus Larynx 2008;35: 515-20.
11. Garacia-Zepeda EA, Rothenberg ME, Owenbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996; 2:449-56.
12. Alam R, Stafford S, Forsythe P et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immumnol 1993;150:3442-8.
13. Takahashi N, Yamada T, Narita N, Fujieda S. Doublestranded RNA induces production of RANTES and IL-8 by human nasal fibroblasts. Clin Immunol 2006;118:51-8.
14. Tian Y, Sommerville LJ, Cuneo A, Kelemen SE, Autieri MV. Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia. Am J Pathol 2008;173: 901-9.
15. Huang F, Wachi S, Thai P et al. Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma. J Allergy Clin Immunol 2008;121:1415-21.
16. Fujieda S, Zhang K, Saxon A. IL-4 plus CD40 monoclonal antibody induces human B cells gamma subclass-specific isotype switch: switching to gamma 1, gamma 3, and gamma4, but not gamma 2. J Immunol 1995;15:2318-28.
17. Gallagher G, Dickensheets H, Eskdale J et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 2000;1:442-50.
18. Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC. STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 2001;167:3545-9.
19. Parrish-Novak J, Xu W, Brender T et al. Interleukins 19, 20 and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 2002;277:47517-23.
20. Marfaing-Koka A, Devergne O, Gorgone G et al. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol 1995;54:1870-8.
21. Hoeck J, Woisetschläger M. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts. J Immunol 2001;166:4507-15.
22. Losman JA, Chen XP, Hilton D, Rothman P. SOCS-1 is a potent inhibitor of IL-4 signal transduction. J Immunol 1999;162:3770-4.
23. Haque SJ, Harbor PC, Williams BR. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling. J Biol Chem 2000;275:26500-6.
24. Seki Y, Hayashi K, Matsumoto A et al. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differ entiation. Proc Natl Acad Sci U S A 2002;99:13003-8.
25. Hebenstreit D, Luft P, Schmiedlechner A, Duschl A, Horejs-Hoeck J. SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells. Mol Immunol 2005;42:295-303.
26. Heller NM, Matsukura S, Georas SN et al. Interferongamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cells. Am J Respir Cell Mol Biol 2004;31:573-82.
27. Sato T, Saito R, Jinushi T et al. IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alpha. Biochem Biophys Res Commun 2004;314:468-75.
28. Wahl C, Müller W, Leithauser F et al. IL-20 receptor 2 signaling down-regulates antigen-specific T cell responses. J Immunol 2009;183:802-10.
29. Hsing CH, Li HH, Hsu YH et al. The distribution of interleukin-19 in healthy and neoplastic tissue. Cytokine 2008;44:221-8.
30. Kunz S, Wolk K, Witte E et al. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol 2006;15:991-1004.
31. Hsing CH, Hsieh MY, Chen WY, Cheung So E, Cheng BC, Chang MS. Induction of interleukin-19 and interleukin-22 after cardiac surgery with cardiopulmonary bypass. Ann Thorac Surg 2006;81:2196-201.
32. Hsing CH, Chiu CJ, Chang LY, Hsu CC, Chang MS. IL-19 is involved in the pathogenesis of endotoxic shock. Shock 2008;29:7-15.
33. Hsing CH, Hsu CC, Chen WY, Chang LY, Hwang JC, Chang MS. Expression of IL-19 correlates with Th2 cytokines in uraemic patients. Nephrol Dial Transplant 2007;22:2230-8.
34. Sa SM, Valdez PA, Wu J et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 2007; 178:2229-40.
35. Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chand MS. IL-19 induces production of IL-6 and TNF-SSand results in cell apoptosis through TNF-i. J Immunol 2002; 169:4288-97.
36. Baetz A, Frey M, Heeg K, Dalpke AH. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate tolllike receptor signaling in innate immune cells. J Biol Chem 2004;279:54708-15.
37. Sakurai N, Kuroiwa T, Ikeuchi H et al. Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatology 2008;47:815-20.